11/21
11:04 am
inbx
Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap [Seeking Alpha]
Medium
Report
Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap [Seeking Alpha]
11/19
07:01 am
inbx
Inhibrx Biosciences (NASDAQ:INBX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Inhibrx Biosciences (NASDAQ:INBX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
11/14
06:37 am
inbx
Inhibrx Biosciences GAAP EPS of -$2.28 [Seeking Alpha]
Medium
Report
Inhibrx Biosciences GAAP EPS of -$2.28 [Seeking Alpha]
11/14
06:07 am
inbx
Inhibrx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Inhibrx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/14
06:00 am
inbx
Inhibrx Reports Third Quarter 2025 Financial Results
Medium
Report
Inhibrx Reports Third Quarter 2025 Financial Results
11/4
04:13 pm
inbx
Inhibrx Announces Participation in Upcoming Scientific Conferences [Yahoo! Finance]
Low
Report
Inhibrx Announces Participation in Upcoming Scientific Conferences [Yahoo! Finance]
11/4
04:01 pm
inbx
Inhibrx Announces Participation in Upcoming Scientific Conferences
Low
Report
Inhibrx Announces Participation in Upcoming Scientific Conferences
10/23
06:46 pm
inbx
Inhibrx shares surge after bone cancer drug slows disease progression in trial [Yahoo! Finance Canada]
High
Report
Inhibrx shares surge after bone cancer drug slows disease progression in trial [Yahoo! Finance Canada]
10/23
04:05 pm
inbx
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
High
Report
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
10/22
04:31 pm
inbx
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts [Yahoo! Finance]
High
Report
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts [Yahoo! Finance]
10/22
04:01 pm
inbx
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
High
Report
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
10/11
08:20 pm
inbx
Owning 45% shares,institutional owners seem interested in Inhibrx Biosciences, Inc. (NASDAQ:INBX), [Yahoo! Finance]
Medium
Report
Owning 45% shares,institutional owners seem interested in Inhibrx Biosciences, Inc. (NASDAQ:INBX), [Yahoo! Finance]
10/6
08:08 am
inbx
Lipidio Pharmaceuticals Expands Advisory Team with Appointment of Renowned Experts Arne Astrup, MD and Mark Lappe [Yahoo! Finance]
Medium
Report
Lipidio Pharmaceuticals Expands Advisory Team with Appointment of Renowned Experts Arne Astrup, MD and Mark Lappe [Yahoo! Finance]